{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T13:34:54Z","timestamp":1787578494279,"version":"build-2736575974"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T00:00:00Z","timestamp":1781222400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T00:00:00Z","timestamp":1787529600000},"content-version":"vor","delay-in-days":73,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Grant of National Natural Science Foundation of China","award":["62271509"],"award-info":[{"award-number":["62271509"]}]},{"name":"Research Project of Fujian Ministry of Science and Technology","award":["2019Y9053"],"award-info":[{"award-number":["2019Y9053"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"DOI":"10.1186\/s12885-026-16333-3","type":"journal-article","created":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T00:46:49Z","timestamp":1781225209000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Impact of time to ablation on survival outcomes in patients with colorectal liver metastases: an inverse probability-weighted cohort study"],"prefix":"10.1186","volume":"26","author":[{"given":"Xiaoning","family":"Yue","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaqing","family":"Kong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyu","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fan","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaojing","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiang","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,12]]},"reference":[{"issue":"1","key":"16333_CR1","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1038\/s41572-021-00261-6","volume":"7","author":"DI Tsilimigras","year":"2021","unstructured":"Tsilimigras DI, Brodt P, Clavien PA, et al. Liver metastases. Nat reviews Disease primers. 2021;7(1):27. https:\/\/doi.org\/10.1038\/s41572-021-00261-6.","journal-title":"Nat reviews Disease primers"},{"issue":"5","key":"16333_CR2","doi-asserted-by":"publisher","first-page":"3374","DOI":"10.1007\/s00464-021-08655-z","volume":"36","author":"L Barkhatov","year":"2022","unstructured":"Barkhatov L, Aghayan DL, Scuderi V, et al. Long-term oncological outcomes after laparoscopic parenchyma-sparing redo liver resections for patients with metastatic colorectal cancer: a European multi-center study. Surg Endosc. 2022;36(5):3374\u201381. https:\/\/doi.org\/10.1007\/s00464-021-08655-z.","journal-title":"Surg Endosc"},{"issue":"3","key":"16333_CR3","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, et al. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. Cancer J Clin. 2021;71(3):209\u201349. https:\/\/doi.org\/10.3322\/caac.21660.","journal-title":"Cancer J Clin"},{"issue":"5","key":"16333_CR4","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1016\/j.jamcollsurg.2009.12.040","volume":"210","author":"MG House","year":"2010","unstructured":"House MG, Ito H, G\u00f6nen M, et al. Survival after hepatic resection for metastatic colorectal cancer: trends in outcomes for 1,600 patients during two decades at a single institution. J Am Coll Surg. 2010;210(5):744\u201352. https:\/\/doi.org\/10.1016\/j.jamcollsurg.2009.12.040. 752\u2009\u2013\u2009745.","journal-title":"J Am Coll Surg"},{"issue":"1","key":"16333_CR5","doi-asserted-by":"publisher","first-page":"171","DOI":"10.21037\/tcr-21-1399","volume":"11","author":"J Chen","year":"2022","unstructured":"Chen J, Chen H, Zhao F, Wang Z, Liu Q. Survival outcomes in unresectable metastatic rectal cancer patients after both primary site resection and chemoradiotherapy: a SEER-based observational study. Transl Cancer Res. 2022;11(1):171\u201380. https:\/\/doi.org\/10.21037\/tcr-21-1399.","journal-title":"Transl Cancer Res"},{"issue":"4","key":"16333_CR6","doi-asserted-by":"publisher","first-page":"300","DOI":"10.21037\/hbsn.2016.02.01","volume":"5","author":"J Hallet","year":"2016","unstructured":"Hallet J, Beyfuss K, Memeo R, Karanicolas PJ, Marescaux J, Pessaux P. Short and long-term outcomes of laparoscopic compared to open liver resection for colorectal liver metastases. Hepatobiliary Surg Nutr. 2016;5(4):300\u201310. https:\/\/doi.org\/10.21037\/hbsn.2016.02.01.","journal-title":"Hepatobiliary Surg Nutr"},{"key":"16333_CR7","doi-asserted-by":"publisher","unstructured":"Benson AB, Venook AP, Adam M, et al. Colon Cancer, Version 3.2024, NCCN Clinical practice guidelines in oncology. J Natl Compr Cancer Network: JNCCN. 2024;22(2 d). https:\/\/doi.org\/10.6004\/jnccn.2024.0029.","DOI":"10.6004\/jnccn.2024.0029"},{"issue":"1","key":"16333_CR8","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.annonc.2022.10.003","volume":"34","author":"A Cervantes","year":"2023","unstructured":"Cervantes A, Adam R, Rosell\u00f3 S, et al. Metastatic colorectal cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up. Annals oncology: official J Eur Soc Med Oncol. 2023;34(1):10\u201332. https:\/\/doi.org\/10.1016\/j.annonc.2022.10.003.","journal-title":"Annals oncology: official J Eur Soc Med Oncol"},{"key":"16333_CR9","doi-asserted-by":"publisher","first-page":"102926","DOI":"10.1016\/j.ctrv.2025.102926","volume":"136","author":"G Bregni","year":"2025","unstructured":"Bregni G, Adams R, Bale R, et al. EORTC consensus recommendations on the optimal management of colorectal cancer liver metastases. Cancer Treat Rev. 2025;136:102926. https:\/\/doi.org\/10.1016\/j.ctrv.2025.102926.","journal-title":"Cancer Treat Rev"},{"issue":"2","key":"16333_CR10","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/s1470-2045(24)00660-0","volume":"26","author":"S van der Lei","year":"2025","unstructured":"van der Lei S, Puijk RS, Dijkstra M, et al. Thermal ablation versus surgical resection of small-size colorectal liver metastases (COLLISION): an international, randomised, controlled, phase 3 non-inferiority trial. Lancet Oncol. 2025;26(2):187\u201399. https:\/\/doi.org\/10.1016\/s1470-2045(24)00660-0.","journal-title":"Lancet Oncol"},{"key":"16333_CR11","doi-asserted-by":"publisher","unstructured":"Tinguely P, Ruiter SJS, Engstrand J, et al. A prospective multicentre trial on survival after microwave ablation versus resection for resectable colorectal liver metastases (MAVERRIC). Eur J cancer (Oxford England: 1990). 2023;187(65\u201376). https:\/\/doi.org\/10.1016\/j.ejca.2023.03.038.","DOI":"10.1016\/j.ejca.2023.03.038"},{"issue":"2","key":"16333_CR12","doi-asserted-by":"publisher","first-page":"e223135","DOI":"10.1148\/radiol.223135","volume":"308","author":"J Li","year":"2023","unstructured":"Li J, Liu G, Xie X, et al. Outcomes following different thermal ablation strategies in patients with unresectable colorectal liver metastases. Radiology. 2023;308(2):e223135. https:\/\/doi.org\/10.1148\/radiol.223135.","journal-title":"Radiology"},{"key":"16333_CR13","doi-asserted-by":"publisher","first-page":"106990","DOI":"10.1016\/j.crad.2025.106990","volume":"88","author":"L Chen","year":"2025","unstructured":"Chen L, Lin J, Cui R, et al. Clinical outcomes of initially unablatable synchronous colorectal liver metastasis after conversion chemotherapy followed by percutaneous microwave ablation. Clin Radiol. 2025;88:106990. https:\/\/doi.org\/10.1016\/j.crad.2025.106990.","journal-title":"Clin Radiol"},{"issue":"2","key":"16333_CR14","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1148\/radiol.2015142489","volume":"278","author":"W Shady","year":"2016","unstructured":"Shady W, Petre EN, Gonen M, et al. Percutaneous radiofrequency ablation of colorectal cancer liver metastases: factors affecting outcomes\u2013a 10-year experience at a single center. Radiology. 2016;278(2):601\u201311. https:\/\/doi.org\/10.1148\/radiol.2015142489.","journal-title":"Radiology"},{"issue":"12","key":"16333_CR15","doi-asserted-by":"publisher","first-page":"2255","DOI":"10.1007\/s10147-021-02024-5","volume":"26","author":"M Ninomiya","year":"2021","unstructured":"Ninomiya M, Emi Y, Motomura T, et al. Efficacy of neoadjuvant chemotherapy in patients with high-risk resectable colorectal liver metastases. Int J Clin Oncol. 2021;26(12):2255\u201364. https:\/\/doi.org\/10.1007\/s10147-021-02024-5.","journal-title":"Int J Clin Oncol"},{"issue":"5","key":"16333_CR16","doi-asserted-by":"publisher","first-page":"4499","DOI":"10.3390\/curroncol30050340","volume":"30","author":"K Tepelenis","year":"2023","unstructured":"Tepelenis K, Pappas-Gogos G, Ntellas P, et al. The role of preoperative chemotherapy in the management of synchronous resectable colorectal liver metastases: a meta-analysis. current oncology (Toronto. Ont). 2023;30(5):4499\u2013511. https:\/\/doi.org\/10.3390\/curroncol30050340.","journal-title":"Ont)"},{"issue":"1","key":"16333_CR17","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1148\/radiol.14132958","volume":"273","author":"M Ahmed","year":"2014","unstructured":"Ahmed M, Solbiati L, Brace CL, et al. Image-guided tumor ablation: standardization of terminology and reporting criteria\u2013a 10-year update. Radiology. 2014;273(1):241\u201360. https:\/\/doi.org\/10.1148\/radiol.14132958.","journal-title":"Radiology"},{"issue":"3","key":"16333_CR18","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1148\/radiol.2021203715","volume":"301","author":"RS Puijk","year":"2021","unstructured":"Puijk RS, Ahmed M, Adam A, et al. Consensus guidelines for the definition of time-to-event end points in image-guided tumor ablation: results of the SIO and DATECAN initiative. Radiology. 2021;301(3):533\u201340. https:\/\/doi.org\/10.1148\/radiol.2021203715.","journal-title":"Radiology"},{"issue":"2","key":"16333_CR19","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1097\/01.sla.0000133083.54934.ae","volume":"240","author":"D Dindo","year":"2004","unstructured":"Dindo D, Demartines N, Clavien PA. Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg. 2004;240(2):205\u201313. https:\/\/doi.org\/10.1097\/01.sla.0000133083.54934.ae.","journal-title":"Ann Surg"},{"issue":"1","key":"16333_CR20","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1007\/s12029-020-00372-5","volume":"52","author":"EY Chen","year":"2021","unstructured":"Chen EY, Mayo SC, Sutton T, et al. Effect of time to surgery of colorectal liver metastases on survival. J Gastrointest cancer. 2021;52(1):169\u201376. https:\/\/doi.org\/10.1007\/s12029-020-00372-5.","journal-title":"J Gastrointest cancer"},{"issue":"1","key":"16333_CR21","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1186\/s12885-025-14135-7","volume":"25","author":"JS Xue","year":"2025","unstructured":"Xue JS, Maimaitiming N, Zhang BL, et al. Prognostic analysis of patients with CRLM based on CRS score: a single-center retrospective study. BMC Cancer. 2025;25(1):718. https:\/\/doi.org\/10.1186\/s12885-025-14135-7.","journal-title":"BMC Cancer"},{"issue":"4","key":"16333_CR22","doi-asserted-by":"publisher","first-page":"102991","DOI":"10.1016\/j.esmoop.2024.102991","volume":"9","author":"R Moretto","year":"2024","unstructured":"Moretto R, Germani MM, Borelli B, et al. Predicting early recurrence after resection of initially unresectable colorectal liver metastases: the role of baseline and pre-surgery clinical, radiological and molecular factors in a real-life multicentre experience. ESMO Open. 2024;9(4):102991. https:\/\/doi.org\/10.1016\/j.esmoop.2024.102991.","journal-title":"ESMO Open"},{"issue":"4","key":"16333_CR23","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1097\/coc.0000000000001076","volume":"47","author":"KR Jethwa","year":"2024","unstructured":"Jethwa KR, Kim E, Berlin J, et al. Executive summary of the american radium society appropriate use criteria for neoadjuvant therapy for nonmetastatic pancreatic adenocarcinoma: systematic review and guidelines. Am J Clin Oncol. 2024;47(4):185\u201399. https:\/\/doi.org\/10.1097\/coc.0000000000001076.","journal-title":"Am J Clin Oncol"},{"key":"16333_CR24","doi-asserted-by":"publisher","unstructured":"Leal JN, Bressan AK, Vachharajani N, et al. Time-to-surgery and survival outcomes in resectable colorectal liver metastases: a multi-institutional evaluation. J Am Coll Surg. 2016;222(5):766\u201379. https:\/\/doi.org\/10.1016\/j.jamcollsurg.2016.01.046.","DOI":"10.1016\/j.jamcollsurg.2016.01.046"},{"issue":"3","key":"16333_CR25","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1177\/0962280220971835","volume":"30","author":"T Liu","year":"2021","unstructured":"Liu T, Hogan JW. Unifying instrumental variable and inverse probability weighting approaches for inference of causal treatment effect and unmeasured confounding in observational studies. Stat Methods Med Res. 2021;30(3):671\u201386. https:\/\/doi.org\/10.1177\/0962280220971835.","journal-title":"Stat Methods Med Res"},{"issue":"3","key":"16333_CR26","doi-asserted-by":"publisher","first-page":"124","DOI":"10.4174\/astr.2015.89.3.124","volume":"89","author":"WK Jeong","year":"2015","unstructured":"Jeong WK, Shin JW, Baek SK. Oncologic outcomes of early adjuvant chemotherapy initiation in patients with stage III colon cancer. Annals Surg Treat Res. 2015;89(3):124\u201330. https:\/\/doi.org\/10.4174\/astr.2015.89.3.124.","journal-title":"Annals Surg Treat Res"},{"issue":"21","key":"16333_CR27","doi-asserted-by":"publisher","first-page":"7849","DOI":"10.1002\/cam4.3283","volume":"9","author":"Q Chen","year":"2020","unstructured":"Chen Q, Mao R, Zhao J, et al. From the completion of neoadjuvant chemotherapy to surgery for colorectal cancer liver metastasis: what is the optimal timing? Cancer Med. 2020;9(21):7849\u201362. https:\/\/doi.org\/10.1002\/cam4.3283.","journal-title":"Cancer Med"},{"key":"16333_CR28","doi-asserted-by":"publisher","first-page":"758552","DOI":"10.3389\/fonc.2021.758552","volume":"11","author":"Y Chen","year":"2021","unstructured":"Chen Y, Xu Y, Xu L, et al. Neoadjuvant chemotherapy followed by radiofrequency ablation prolongs survival for ablatable colorectal liver metastasis: a propensity score matching comparative study. Front Oncol. 2021;11:758552. https:\/\/doi.org\/10.3389\/fonc.2021.758552.","journal-title":"Front Oncol"},{"issue":"34","key":"16333_CR29","doi-asserted-by":"publisher","first-page":"3789","DOI":"10.1200\/jco.21.01032","volume":"39","author":"Y Kanemitsu","year":"2021","unstructured":"Kanemitsu Y, Shimizu Y, Mizusawa J, et al. Hepatectomy followed by mFOLFOX6 versus hepatectomy alone for liver-only metastatic colorectal cancer (JCOG0603): A phase II or III randomized controlled trial. J Clin Oncol. 2021;39(34):3789\u201399. https:\/\/doi.org\/10.1200\/jco.21.01032.","journal-title":"J Clin Oncol"},{"issue":"7","key":"16333_CR30","doi-asserted-by":"publisher","first-page":"1281","DOI":"10.4251\/wjgo.v14.i7.1281","volume":"14","author":"K Takeda","year":"2022","unstructured":"Takeda K, Sawada Y, Yabushita Y, et al. Efficacy of neoadjuvant chemotherapy for initially resectable colorectal liver metastases: a retrospective cohort study. World J Gastrointest Oncol. 2022;14(7):1281\u201394. https:\/\/doi.org\/10.4251\/wjgo.v14.i7.1281.","journal-title":"World J Gastrointest Oncol"},{"issue":"2","key":"16333_CR31","doi-asserted-by":"publisher","first-page":"e82","DOI":"10.1016\/j.clcc.2020.09.005","volume":"20","author":"I Kurilova","year":"2021","unstructured":"Kurilova I, Bendet A, Petre EN, et al. Factors associated with local tumor control and complications after thermal ablation of colorectal cancer liver metastases: a 15-year retrospective cohort study. Clin Colorectal Cancer. 2021;20(2):e82\u201395. https:\/\/doi.org\/10.1016\/j.clcc.2020.09.005.","journal-title":"Clin Colorectal Cancer"},{"key":"16333_CR32","doi-asserted-by":"publisher","unstructured":"Chlorogiannis DD, Sotirchos VS, Georgiades C, et al. The importance of optimal thermal ablation margins in colorectal liver metastases: a systematic review and meta-analysis of 21 studies. Cancers. 2023;15(24). https:\/\/doi.org\/10.3390\/cancers15245806.","DOI":"10.3390\/cancers15245806"},{"issue":"5","key":"16333_CR33","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1016\/s2468-1253(25)00024-x","volume":"10","author":"BC Odisio","year":"2025","unstructured":"Odisio BC, Albuquerque J, Lin YM, et al. Software-based versus visual assessment of the minimal ablative margin in patients with liver tumours undergoing percutaneous thermal ablation (COVER-ALL): a randomised phase 2 trial. lancet Gastroenterol Hepatol. 2025;10(5):442\u201351. https:\/\/doi.org\/10.1016\/s2468-1253(25)00024-x.","journal-title":"lancet Gastroenterol Hepatol"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12885-026-16333-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-026-16333-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-026-16333-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T13:11:52Z","timestamp":1787577112000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12885-026-16333-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,12]]},"references-count":33,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["16333"],"URL":"https:\/\/doi.org\/10.1186\/s12885-026-16333-3","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,12]]},"assertion":[{"value":"26 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This retrospective study was approved by the Ethics Committees of the two participating centers (Approval Number: 25\/104\u20135050), and the requirement for informed consent was waived. The study was conducted in accordance with the Declaration of Helsinki.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"1011"}}